These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2300595)

  • 21. Effect of changes in perfusion pressure on renal and urinary kallikrein in the isolated perfused rat kidney.
    Bönner G; Schwertschlag U; Marin-Grez M; Gross F
    Ren Physiol; 1983; 6(6):288-94. PubMed ID: 6557616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary kallikrein in rats bred for their susceptibility and resistance to the hypertensive effect of salt. A new radioimmunoassay for its direct determination.
    Carretero OA; Amin VM; Ocholik T; Scicli AG; Koch J
    Circ Res; 1978 May; 42(5):727-31. PubMed ID: 639196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormalities in kallikrein excretion in spontaneously hypertensive rats.
    Ader JL; Pollock DM; Butterfield MI; Arendshorst WJ
    Am J Physiol; 1985 Mar; 248(3 Pt 2):F396-403. PubMed ID: 3844907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure sensitivity to salt in rats with low urinary kallikrein excretion.
    Madeddu P; Varoni MV; Demontis MP; Pinna-Parpaglia P; Glorioso N; Anania V
    Immunopharmacology; 1996 Jun; 33(1-3):301-4. PubMed ID: 8856169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive effect of MK-421 in rats. Role of the renal kallikrein-kinin system.
    Yasujima M; Abe K; Tanno M; Kasai Y; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
    Hypertension; 1984; 6(2 Pt 1):229-35. PubMed ID: 6327517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanism of urinary kallikrein excretion in the rat.
    Martínez Seeber A; Vila SB; Catanzaro OL
    Clin Sci (Lond); 1982 Aug; 63(2):217-8. PubMed ID: 6919474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of atrial natriuretic peptide (ANP) on the renal kallikrein-kinin system in normotensive and spontaneously hypertensive rats].
    Bönner G; Hirzel B; Ganten D; Kaufmann W
    Z Kardiol; 1988; 77 Suppl 2():85-91. PubMed ID: 2841816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.
    Chiang WC; Lin SL; Chen YM; Wu KD; Tsai TJ
    Nephrology (Carlton); 2008 Jun; 13(3):198-203. PubMed ID: 18315702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of aprotinin (a serine protease inhibitor) on renal function and renin release.
    Seto S; Kher V; Scicli AG; Beierwaltes WH; Carretero OA
    Hypertension; 1983; 5(6):893-9. PubMed ID: 6197374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic effects of norepinephrine and vasopressin on urinary prostaglandin E and kallikrein excretions in conscious rats.
    Yasujima M; Abe K; Tanno M; Sato K; Kasai Y; Seino M; Chiba S; Goto T; Omata K; Tajima J
    Clin Exp Hypertens A; 1984; 6(7):1297-310. PubMed ID: 6565534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inverse relationship between renal and urinary kallikrein during chromate-induced acute renal failure in rat: urinary kallikrein excretion as a possible recovery index.
    Girolami JP; Orfila C; Pecher C; Cabos-Boutot G; Bascands JL; Moatti JP; Adam A; Colle A
    Biol Chem Hoppe Seyler; 1989 Dec; 370(12):1305-13. PubMed ID: 2619924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kallikrein excretion in Dahl salt-sensitive and salt-resistant rats with native and transplanted kidneys.
    Churchill PC; Churchill MC; Bidani AK; Rabito SF
    Am J Physiol; 1995 Nov; 269(5 Pt 2):F710-7. PubMed ID: 7503238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat.
    Jaffa AA; Vio CP; Silva RH; Vavrek RJ; Stewart JM; Rust PF; Mayfield RK
    J Clin Invest; 1992 May; 89(5):1460-8. PubMed ID: 1373739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sympathetic nervous system mediates urinary kallikrein excretion in conscious rats.
    Albertini R; Vargas L; Oliveri P; Pardo F; Paredes MC
    Clin Exp Pharmacol Physiol; 1987 Apr; 14(4):291-301. PubMed ID: 3117464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced ratio of active-to-total urinary kallikrein in essential hypertension.
    Lieberthal W; Arbeit L; Oza NB; Bernard DB; Levinsky NG
    Hypertension; 1983; 5(4):603-9. PubMed ID: 6345366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of vasopressin in regulation of renal kinin excretion in Long-Evans and diabetes insipidus rats.
    Kauker ML; Crofton JT; Share L; Nasjletti A
    J Clin Invest; 1984 Mar; 73(3):824-31. PubMed ID: 6561201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Micropuncture localization of kallikrein secretion in the rat nephron.
    Beasley D; Oza NB; Levinsky NG
    Kidney Int; 1987 Jul; 32(1):26-30. PubMed ID: 3650556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total and kallikrein arginine esterase activities in the urine of salt-hypertensive susceptible and resistant rats.
    Sustarsic DL; McPartland RP; Rapp JP
    Hypertension; 1980; 2(6):813-20. PubMed ID: 7007238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dihydralazine on the renal kallikrein-kinin system of the rat.
    Bönner G; Beck D; Deeg M; Marin-Grez M; Gross F
    Eur J Pharmacol; 1982 Feb; 78(2):219-23. PubMed ID: 6918300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased urinary active and inactive kallikrein by chronic infusion of vasopressin in conscious rats.
    Yasujima M; Abe K; Tanno M; Omata K; Kasai Y; Sato M; Kimura T; Yoshinaga K
    Tohoku J Exp Med; 1985 Feb; 145(2):215-22. PubMed ID: 3846407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.